
New Combinations of Glioblastoma Drugs May Improve a Dismal Prognosis
Early this month, Novocure announced that the first patient was enrolled in the RTOG Foundation's Phase 2 pilot trial for recurrent glioblastoma. This trial is aimed to test the safety and…